Polysomnography Devices Market Size & Share, by Type (Fixed, Portable); Channel (>10,>16, >32, >56); Application (Hospitals, Diagnostic Laboratories, Homecare Settings) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 5500
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Polysomnography Devices Market size was valued at USD 291.09 million in 2024 and is set to exceed USD 515.87 million by 2037, registering over 4.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of polysomnography devices is evaluated at USD 301.57 million.

The reason behind the growth is due to the lack of sleep prevalence across the globe. A significant portion of the population still struggles with getting enough sleep, owing to longer work hours, more pressures, and continual access to social media and entertainment. For instance, more than 60% of adults globally report having trouble falling asleep at night which is affecting their mental and physical well-being.

The growing awareness about sleep disorders is believed to fuel the polysomnography devices market growth. For instance, every year, World Sleep Day is observed to increase public awareness, and research in the field of sleep disorders to lessen the impact of sleep disorders on society.


Get more information on this report: Request Free Sample PDF

Polysomnography Devices Market: Growth Drivers and Challenges

Growth Drivers

  • Rising Burden of Sleep Disorders in Patients with Chronic Obstructive Pulmonary Disease (COPD) - Sleep disturbances such as respiratory effort-related arousals (RERAs), central sleep apnea, obstructive sleep apnea, sleep-related hypoventilation, and hypoxemia during sleep are commonly linked to chronic pulmonary illnesses which may result in nighttime awakenings due to symptoms including heartburn, coughing, wheezing, dyspnea, and nasal congestion. For instance, it has been estimated that between 30% and 80% of COPD patients report having sleep disturbances. Particularly, in COPD patients, the prevalence of obstructive sleep apnea, and sleeplessness was around 29%, and 29%, respectively.
  • Growing Sleep Disorders in the Geriatric Population- Approximately half of those over 55 struggle to fall asleep since the aging process alters sleeping habits, anxiety levels, and numerous other factors. For instance, chronic sleep disorders are thought to affect over 45% of older persons.
  • Increasing Prevalence of Obesity- Obese people are more likely to experience sleeping problems. Particularly, over 15% of obese people have sleep apnea, as compared to around 2% of people with normal weight.

Challenges

  • Lack of Awareness About Sleep Disorders- Sleep deprivation negatively affects both mental and physical health and can eventually result in several health problems and mental health issues. However, the public, medical professionals, and authorities, in general, are not aware of the issue that sleepy drivers present since the majority of individuals are ignorant of how much sleep they require, and how detrimental sleep deprivation is to their health. Therefore, global emphasis on awareness, research, and focused public health policies are required to promote sleep health, and sleep should be included in health screenings similar to those aimed at quitting smoking and reducing excessive alcohol consumption.
  • Shortage of Medical Laboratory Technologies and Specialists Resulting in Delays in Conducting Polysomnography Tests
  • Limited Accessibility to Sleep Diagnostic Technologies in Low Economic Areas.

Polysomnography Devices Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

4.5%

Base Year Market Size (2024)

USD 291.09 million

Forecast Year Market Size (2037)

USD 515.87 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Polysomnography Devices Segmentation

Type (Fixed, Portable)

The fixed segment in the polysomnography devices market is estimated to gain a robust revenue share of 64% in the coming years owing to the growing burden of obstructive sleep apnea (OSA). For instance, it is estimated that more than 930 million persons worldwide suffer from mild to severe obstructive sleep apnea (OSA). It is a widespread chronic sleep-related breathing disorder characterized by recurring bouts of hypopnea and apnea and is known to be one of the most prevalent co-morbidities among individuals with interstitial lung disease (ILD). Moreover, it has been reported that the prevalence of OSA in ILD ranges from around 15–85%, while in healthy adults, it is over 3%. Interstitial lung diseases are a diverse set of conditions that may lead to increased BMI which is a significant risk factor for OSA.

To diagnose OSA, polysomnography (PSG) or overnight sleep study, is necessary which may necessitate the use of fixed polysomnography equipment for sleep staging in individuals. These devices are often used in sleep laboratories to detect conditions including OSA through the use of multiple sensors. Particularly, they allow medical professionals to observe abnormalities during an entire night’s sleep and tailor the treatment procedures accordingly.

Additionally, for a thorough examination of sleep, the portable polysomnograph records eight electrophysiological signals to provide more accurate readings when working in a laboratory. It is used by numerous clinics and hospitals since they can be customized, and are available at extremely affordable prices.

Application (Hospitals, Diagnostic Laboratories, Homecare Settings)

The diagnostic laboratories segment in the polysomnography devices market is set to garner a notable share shortly. A sleep diagnostic lab specializes in the diagnosis of several sleep-related conditions whereby overnight sleep behavior and pattern is monitored which is required for early diagnosis and treatment. These sleep labs have a bedroom-style configuration with sensors that are affixed to the patient's head using a thin layer of adhesive that aids in the examination of heart rate, respiration patterns, brain activity, blood oxygen level, eye and leg movements, and heart rate.

Furthermore, in homecare settings, polysomnography devices are being used for easy sleep investigations as they are affordable and easy to use. Besides this, these gadgets can be utilized for research on sleep problems in medical facilities or hospitals under the guidance of skilled specialists to prevent negative health effects.

Our in-depth analysis of the global polysomnography devices market includes the following segments:

Type

  • Fixed
  • Portable

Voltage

  • >10
  • >16
  • >32
  • >56

Application

  • Hospitals
  • Diagnostic Laboratories
  • Homecare Settings

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Polysomnography Devices Industry- Regional Synopsis

North American Market Forecast

The polysomnography devices market in North America is predicted to account for the largest share of 46% by 2037 impelled by growing mergers and acquisitions, leading to the release of more products onto the polysomnography devices market. For instance, in December 2022, Natus Medical Inc. a well-known company that supplies medical supplies used for sleep disorders announced the acquisition of Micromed Holding SAS to combine its brands such as NeuroWorks/SleepWorks, Natus Quantum, and others with the complete line of Micromed solutions to develop new products in the fields of polysomnography (PSG), and other fields.

APAC Market Statistics

The Asia Pacific polysomnography devices market is estimated to be the second largest, during the forecast timeframe led by the inclusion of polysomnography in health insurance coverage.

For instance, The Government Rajaji Hospital (GRH) in India introduced a polysomnography device at the sleep laboratory that is available at no cost under the chief minister's comprehensive health insurance policy.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Polysomnography Devices Market

    • Nox Medical
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BMC Medical
    • CleveMed
    • Recorders & Medicare Systems
    • Medicom MTD
    • Compumedics
    • Dr. Langer Medical
    • Neurovirtual
    • Shanghai NCC Medica
    • Contec Medical Systems.
    •  CleveMed
    • SOMNOmedics GmbH
    • Cidelec
    • ResMed
    • Vyaire Medical
    • Natus Medical
    • Koninklijke Philips
    • Bittium Biosignals Ltd.

In the News

  • Nox Medical announced the introduction of Nox A1s PSG system with telehealth capabilities to perform in-lab and at-home sleep testing to enable sleep specialists to support scalable clinical pathways and assist a greater number of individuals in achieving improved sleep, improving patient comfort, clinical accuracy, and overall efficiency in mind.
  • ResMed teamed up with Bittium Biosignals Ltd, under which ResMed becomes a distributor of Bittium Respiro the advanced Home Sleep Apnea Test and Analysis Solution including Bittium Respiro measuring device and its accessories, as well as Bittium Respiro Analyst software analyzing tool and service platform that focuses on measuring nighttime polygraphy at home to record and assesses typical cases of sleep-disordered breathing by using artificial intelligence to improve the analysis process's efficiency.

Author Credits:  Radhika Pawar


  • Report ID: 5500
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of polysomnography devices is evaluated at USD 301.57 million.

The polysomnography devices market size was valued at USD 291.09 million in 2024 and is set to exceed USD 515.87 million by 2037, registering over 4.5% CAGR during the forecast period i.e., between 2025-2037. Lack of sleep prevalence across the globe and the growing awareness about sleep disorders will drive the market growth.

North America industry is predicted to hold largest revenue share of 46% by 2037, impelled by growing mergers and acquisitions in the region.

The major players in the market include Nox Medical, BMC Medical, CleveMed, Recorders & Medicare Systems, Medicom MTD, Compumedics, Dr. Langer Medical, Neurovirtual, Shanghai NCC Medica, Contec Medical Systems., CleveMed, SOMNOmedics GmbH, Cidelec, ResMed, Vyaire Medical, Natus Medical, Koninklijke Philips, Bittium Biosignals Ltd.
Polysomnography Devices Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample